Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Non-Standardized Fungal Allergenic Extract [EPC]
Sus Scrofa Colon is a non-standardized biological extract derived from porcine large intestine, primarily utilized in allergenic extracts and organotherapy to modulate immune responses and support gastrointestinal health under clinical supervision.
Name
Sus Scrofa Colon
Raw Name
SUS SCROFA COLON
Category
Non-Standardized Fungal Allergenic Extract [EPC]
Drug Count
13
Variant Count
13
Last Verified
February 17, 2026
About Sus Scrofa Colon
Sus Scrofa Colon is a non-standardized biological extract derived from porcine large intestine, primarily utilized in allergenic extracts and organotherapy to modulate immune responses and support gastrointestinal health under clinical supervision.
Detailed information about Sus Scrofa Colon
References used for this content
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Sus Scrofa Colon.
Sus Scrofa Colon is a biological substance derived from the porcine (pig) large intestine. In the realm of clinical pharmacology and immunology, it is classified primarily as a Non-Standardized Fungal Allergenic Extract [EPC], though it often appears in complex formulations alongside other classes such as Non-Standardized Plant Allergenic Extracts, Vitamin D, and Nicotinic Acid. The term "Sus Scrofa" refers to the domestic pig, a species frequently used in medical science due to its physiological and anatomical similarities to humans. The "Colon" designation indicates that the extract is specifically harvested from the mucosal or muscular layers of the porcine large intestine.
Clinically, Sus Scrofa Colon belongs to a class of drugs known as biological extracts or organotherapeutic agents. These substances are historically rooted in the practice of using animal-derived tissues to support or modulate the function of corresponding human organs. While its classification as a "Fungal Allergenic Extract" in certain regulatory databases may seem counterintuitive, it reflects its use in immunotherapy protocols where porcine-derived proteins are used to desensitize patients or modulate specific immune pathways related to mucosal integrity and environmental sensitivities.
According to the FDA's historical perspective on non-standardized extracts, these products do not have a defined potency measured in specific units (like International Units). Instead, they are prepared according to established manufacturing processes that preserve the protein profile of the source material. Sus Scrofa Colon has been utilized in various homeopathic and integrative medicine frameworks for decades, often marketed under the Homeopathic Pharmacopoeia of the United States (HPUS) guidelines, though its status as a primary allergenic extract remains a specialized niche in clinical immunology.
The mechanism of action for Sus Scrofa Colon is multifaceted and depends largely on its application. At the molecular level, the extract contains a complex array of porcine proteins, enzymes, and signaling molecules that are thought to interact with the human immune system through a process known as bystander suppression or immune modulation.
When administered as an allergenic extract, Sus Scrofa Colon introduces small, controlled amounts of porcine antigens to the patient's immune system. This exposure is designed to shift the immune response from a Th2-dominated pathway (associated with allergic inflammation and IgE production) to a Th1-dominated or T-regulatory (Treg) pathway. This shift results in the production of IgG4 antibodies, which act as "blocking antibodies" to prevent the allergic cascade.
In the context of gastrointestinal support, proponents of organotherapy suggest that the specific peptides and growth factors found in the porcine colon extract may provide the building blocks necessary for mucosal repair. This is often referred to as the "homing principle," where components of the animal organ are hypothesized to support the homologous organ in the human body. However, from a strictly pharmacological standpoint, the primary action is likely mediated through the Gut-Associated Lymphoid Tissue (GALT). By interacting with the Peyer's patches in the human intestine, the extract may influence systemic cytokine production, potentially reducing inflammatory markers such as TNF-alpha and Interleukin-6 (IL-6).
Understanding the pharmacokinetics of a complex biological extract like Sus Scrofa Colon differs significantly from traditional small-molecule drugs.
Sus Scrofa Colon is utilized in several clinical contexts, though many uses are considered "non-standardized" or part of integrative medicine protocols:
Sus Scrofa Colon is available in several specialized dosage forms:
> Important: Only your healthcare provider can determine if Sus Scrofa Colon is right for your specific condition. Because it is a biological product, the risk of contamination or improper immune activation must be managed by a medical professional.
Dosage for Sus Scrofa Colon is highly individualized and depends on the specific formulation and the condition being treated.
Sus Scrofa Colon should be used in pediatric populations only under the direct supervision of a specialist, such as a pediatric allergist or integrative pediatrician.
No specific dose adjustments are provided for patients with renal impairment, as the proteins are metabolized proteolytically. However, patients with end-stage renal disease (ESRD) should be monitored for fluid balance if using liquid formulations containing alcohol as a preservative.
No dosage adjustment is typically required for hepatic impairment. However, if Sus Scrofa Colon is used in combination with Nicotinic Acid, liver function must be monitored closely, as Nicotinic Acid can be hepatotoxic at high doses.
Elderly patients should start at the lower end of the dosing spectrum. The aging immune system (immunosenescence) may respond less predictably to allergenic extracts, increasing the risk of either reduced efficacy or delayed hypersensitivity reactions.
If you miss a dose of Sus Scrofa Colon, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and resume your regular schedule. Do not double the dose to catch up. In the case of injectable immunotherapy, missing a dose for more than a week may require a dose reduction for safety; contact your allergist immediately.
Signs of an acute overdose of Sus Scrofa Colon are primarily related to hyper-immune stimulation. Symptoms may include:
In the event of a suspected overdose, especially if respiratory distress occurs, seek emergency medical attention or contact a poison control center immediately. Treatment is supportive and may include the administration of antihistamines or epinephrine.
> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your dose or frequency without medical guidance, as this can lead to treatment failure or dangerous allergic reactions.
Patients taking Sus Scrofa Colon, particularly in the form of allergenic extracts or concentrated oral supplements, may experience the following common side effects:
> Warning: Stop taking Sus Scrofa Colon and call your doctor immediately or seek emergency care if you experience any of the following:
Because Sus Scrofa Colon is often used for extended periods in immunotherapy, long-term effects must be considered:
No FDA black box warnings currently exist specifically for Sus Scrofa Colon. However, it is important to note that many allergenic extracts carry a general warning regarding the risk of severe non-fatal and fatal systemic allergic reactions. These products should only be administered in settings equipped to treat anaphylaxis, and patients should be observed for at least 30 minutes following an injection.
Report any unusual symptoms or persistent side effects to your healthcare provider. Monitoring of systemic inflammatory markers may be recommended during long-term therapy.
Sus Scrofa Colon is a biological product derived from animal tissue. Its use carries inherent risks that must be balanced against its potential benefits. Patients must be aware that non-standardized extracts do not have the same level of batch-to-batch consistency as synthetic pharmaceuticals. Always ensure the product is sourced from a reputable manufacturer that adheres to Good Manufacturing Practices (GMP) and rigorous pathogen screening.
As of 2024, there are no specific FDA black box warnings for Sus Scrofa Colon. However, clinicians often apply the warnings associated with the broader class of Allergenic Extracts. These warnings emphasize that the product can cause severe, life-threatening anaphylaxis. Patients with unstable asthma or those taking beta-blockers are at a significantly higher risk of complications if a systemic reaction occurs.
Patients on long-term Sus Scrofa Colon therapy should undergo regular monitoring:
Sus Scrofa Colon generally does not cause drowsiness. However, if a systemic allergic reaction occurs, symptoms like dizziness or fainting can impair your ability to drive. It is recommended to wait at least 30 minutes after an injection before operating a vehicle.
There is no direct contraindication between alcohol and Sus Scrofa Colon. However, alcohol is a vasodilator and can increase the speed of absorption of antigens, potentially increasing the risk of a systemic reaction. It is best to avoid alcohol for several hours before and after a dose, especially during the build-up phase of immunotherapy.
Do not stop taking Sus Scrofa Colon suddenly if you are using it for desensitization, as this can result in a loss of the immunological tolerance built up during treatment. If you must discontinue, your doctor will provide a tapering schedule or instructions on how to safely restart therapy at a lower dose in the future.
> Important: Discuss all your medical conditions, including any history of autoimmune disease or severe allergies, with your healthcare provider before starting Sus Scrofa Colon.
For each major interaction, the management strategy usually involves either a dose adjustment of the extract or a temporary suspension of the interacting medication.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, including over-the-counter allergy medications.
Sus Scrofa Colon must NEVER be used in the following circumstances:
Conditions requiring careful risk-benefit analysis include:
Patients should be aware of potential cross-sensitivity with:
> Important: Your healthcare provider will evaluate your complete medical history, including any rare allergies or family history of immune disorders, before prescribing Sus Scrofa Colon.
Sus Scrofa Colon is generally classified in a category equivalent to FDA Category C. There are no adequate and well-controlled studies in pregnant women. The primary risk during pregnancy is not the extract itself, but the potential for a systemic allergic reaction (anaphylaxis) in the mother. Anaphylaxis can lead to maternal hypotension, which in turn causes placental hypoperfusion and fetal hypoxia (lack of oxygen to the baby).
It is unknown whether the antigenic components of Sus Scrofa Colon are excreted in human milk. However, because most of the proteins are broken down into amino acids in the maternal digestive tract, the risk to a nursing infant is considered low. The primary concern remains the mother's risk of a reaction. Decisions should be made based on the necessity of the treatment for the mother's health.
Sus Scrofa Colon is used in children, particularly in the context of allergenic extracts for desensitization.
In patients over 65, several factors must be considered:
While the kidneys are not the primary site of metabolism for Sus Scrofa Colon, patients with significant renal impairment (GFR < 30 mL/min) should be monitored for any signs of systemic accumulation of metabolites or changes in blood pressure during therapy. No specific dosage adjustment formulas have been established.
In patients with Child-Pugh Class B or C hepatic impairment, the synthesis of proteins and immune factors may be altered. While Sus Scrofa Colon does not undergo hepatic metabolism via the CYP system, the overall altered state of the immune system in liver disease warrants a cautious approach and lower starting doses.
> Important: Special populations require individualized medical assessment. Always inform your specialist about your pregnancy status or any age-related health concerns.
Sus Scrofa Colon acts as an immunomodulator. Its primary molecular mechanism involves the presentation of porcine-derived colonic antigens to human Antigen-Presenting Cells (APCs), such as dendritic cells. Once processed, these antigens are presented to T-cells.
In an allergic or inflammatory state, the immune system often over-responds via the Th2 pathway. Sus Scrofa Colon therapy aims to induce peripheral tolerance. This is achieved through the induction of Regulatory T-cells (Tregs) that secrete inhibitory cytokines like Interleukin-10 (IL-10) and Transforming Growth Factor-beta (TGF-β). These cytokines suppress the activity of IgE-producing B-cells and eosinophils. Furthermore, the extract may contain specific porcine microRNAs or peptides that have a direct signaling effect on the human colonic mucosa, potentially upregulating tight junction proteins like claudin and occludin, thereby improving barrier function.
| Parameter | Value |
|---|---|
| Bioavailability | Low for intact proteins; High for peptide fragments |
| Protein Binding | N/A (Metabolized as protein) |
| Half-life | 24-48 hours (physical); Months (immunological) |
| Tmax | 1-4 hours (for small peptides) |
| Metabolism | Proteolytic degradation (cellular proteases) |
| Excretion | Renal (metabolites); Fecal (unabsorbed) |
Sus Scrofa Colon is classified as a Non-Standardized Fungal Allergenic Extract [EPC] in some regulatory systems, but it is more accurately described as a porcine-derived biological extract. It shares therapeutic space with other allergenic extracts (like grass or dust mite extracts) and organotherapeutic substances used in integrative medicine.
Medications containing this ingredient
Common questions about Sus Scrofa Colon
Sus Scrofa Colon is primarily used as a non-standardized allergenic extract for immune desensitization and as an organotherapeutic supplement to support gastrointestinal health. In clinical immunology, it helps the body build tolerance to porcine-derived antigens, while in integrative medicine, it is used to provide the biological building blocks for mucosal repair. It is often found in complex formulations that may include Vitamin D or Nicotinic Acid. Some healthcare providers use it to address chronic functional bowel issues by modulating the Gut-Associated Lymphoid Tissue (GALT). Always consult a specialist to determine if this biological extract is appropriate for your specific clinical needs.
The most common side effects include mild gastrointestinal upset, such as nausea or bloating, and local reactions if the product is injected. For those using sublingual drops, a mild tingling or itching sensation in the mouth is frequently reported. These symptoms are usually transient and resolve as the body becomes accustomed to the porcine proteins. However, because it is an allergenic extract, more significant reactions like hives or mild rashes can occur. If you notice any persistent or worsening symptoms, it is vital to contact your healthcare provider immediately to discuss a possible dose adjustment.
While there is no direct chemical interaction between alcohol and Sus Scrofa Colon, caution is strongly advised. Alcohol acts as a vasodilator, which can increase the rate at which the porcine antigens are absorbed into your bloodstream, potentially raising the risk of a systemic allergic reaction. It is generally recommended to avoid alcohol for at least several hours before and after taking your dose, especially during the initial phase of treatment. Furthermore, alcohol can irritate the gastrointestinal lining, which may counteract the mucosal-supportive benefits of the extract. Discuss your alcohol consumption habits with your doctor before starting therapy.
Sus Scrofa Colon is generally not recommended for initiation during pregnancy due to the risk of anaphylaxis, which can be dangerous for both the mother and the developing fetus. If a woman is already on a stable maintenance dose before becoming pregnant, her doctor may choose to continue the treatment, but the dose is typically not increased. There is a lack of large-scale clinical data regarding the teratogenic effects of porcine colon extracts. Therefore, the decision to use this product during pregnancy must involve a careful risk-benefit analysis by an allergist or maternal-fetal medicine specialist. Always inform your doctor immediately if you become pregnant while using this product.
The onset of action for Sus Scrofa Colon is relatively slow because it relies on modulating the immune system's memory. While some patients may notice a minor improvement in digestive symptoms within a few weeks, the full therapeutic effect—especially for desensitization—typically takes 3 to 6 months of consistent use. For long-term immune tolerance, a treatment course often lasts between 3 and 5 years. It is important to remain patient and compliant with the dosing schedule. If you do not see any improvement after several months, your healthcare provider may need to re-evaluate the concentration or the frequency of your doses.
You should not stop taking Sus Scrofa Colon suddenly without consulting your doctor, particularly if you are using it as part of an immunotherapy or desensitization program. Abrupt discontinuation can cause your immune system to lose the tolerance it has built up, which may lead to a recurrence of symptoms or an increased risk of a reaction when you try to restart the medication. If you need to stop the medication due to side effects, your doctor will guide you through a safe discontinuation process. For those taking it as a nutritional supplement, stopping suddenly is generally safe but may result in the return of the original gastrointestinal complaints.
If you miss a dose of Sus Scrofa Colon, take it as soon as you remember, unless it is nearly time for your next scheduled dose. In that case, skip the missed dose and continue with your regular routine; never double your dose to compensate. For those receiving injections, missing a dose for more than a week is more critical, as your sensitivity to the extract may have increased. You must call your allergist's office before your next injection, as they may need to reduce the dose for safety. Consistency is key to the success of biological extracts, so try to take your doses at the same time each day.
There is no clinical evidence to suggest that Sus Scrofa Colon directly causes weight gain. The extract consists primarily of proteins and peptides in very small amounts that do not contribute significantly to your daily caloric intake. However, if the extract successfully treats a chronic gastrointestinal condition that was causing malabsorption or weight loss, you may experience a return to your healthy baseline weight. If you notice rapid or unexplained weight gain while taking this or any other medication, you should discuss it with your healthcare provider to rule out other underlying causes such as fluid retention or metabolic changes.
Sus Scrofa Colon can interact with several types of medications, most notably beta-blockers and immunosuppressants. Beta-blockers can make allergic reactions more severe and harder to treat, while immunosuppressants may prevent the extract from working effectively. It is also important to be cautious when taking it with other vitamins like Vitamin D or Nicotinic Acid, as they are often co-classified. Always provide your healthcare provider with a complete list of all prescription drugs, over-the-counter medicines, and herbal supplements you are taking. This allows them to screen for potential interactions and ensure that Sus Scrofa Colon is safe for you.
Because Sus Scrofa Colon is a complex biological extract rather than a simple synthetic chemical, the concept of a 'generic' version is slightly different. It is available from various manufacturers as a non-standardized extract, often under different brand names or as part of homeopathic formulations. These products may vary in their concentration and the specific porcine tissue processing methods used. While there may be lower-cost versions available, they are not always bioequivalent in the way that generic tablets are. It is best to stay with the specific brand or formulation recommended by your specialist to ensure consistent results and safety.